{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/c767ec47-5295-448a-9f75-4f55ed84bfe8/3fad3682-9e6f-40e4-bc34-4ad179dc4120?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Biotek-aksjen opp over 200 prosent","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/6172b70fc3f6d966b7c1dfcf/6172b83a1651190014365d34.jpg?height=200","description":"Gjest: Joakim Hannisdahl, Cleaves Securities","author_name":"Finansavisen"}